| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000009428 |
| Receipt No. | R000011077 |
| Scientific Title | Clinical trial of regenerative medicine for hemophilic arthropathy using human mesenchymal stem cells |
| Date of disclosure of the study information | 2013/04/01 |
| Last modified on | 2020/12/09 (Ver. 7) |
| Basic information | ||
| Public title | Clinical trial of regenerative medicine for hemophilic arthropathy using human mesenchymal stem cells | |
| Acronym | Regenerative medicine for hemophilic arthropathy | |
| Scientific Title | Clinical trial of regenerative medicine for hemophilic arthropathy using human mesenchymal stem cells | |
| Scientific Title:Acronym | Regenerative medicine for hemophilic arthropathy | |
| Region |
|
|
| Condition | ||
| Condition | Hemophilic knee arthropathy | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Establishment on novel therapy for hemophilic arthropathy |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Safety of the transplanted patients |
| Key secondary outcomes | 1)repair of cartilage evaluated by MRI
2)Improvement of clinical symptoms and joint function |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Joint infusion of human mesenchymal stem cells | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | progressive hemophilic knee arthropathy
non-inhibitor covered with prophylaxis treatment |
|||
| Key exclusion criteria | DM
Antibody(+) of HCV, HIV liver dysfunction anemia renal dysfunction drug allergy |
|||
| Target sample size | 5 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Department of Joint Surgery | ||||||
| Division name | Research Hospital of the Institute of Medical Science The University of Tokyo | ||||||
| Zip code | 1088639 | ||||||
| Address | minatoku | ||||||
| TEL | 0334438111 | ||||||
| takedani@ims.u-tokyo.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | IMUST hosipital | ||||||
| Division name | Research Hospital of the Institute of Medical Science The University of Tokyo | ||||||
| Zip code | 1088639 | ||||||
| Address | minatoku | ||||||
| TEL | 0334438111 | ||||||
| Homepage URL | |||||||
| takedani@ims.u-tokyo.ac.jp | |||||||
| Sponsor | |
| Institute | Research Hospital of the Institute of Medical Science
The University of Tokyo |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Research Hospital of the Institute of Medical Science The University of Tokyo |
| Address | 4-6-1 Shiroganedai, Minato-ku, Tokyo |
| Tel | +81334438111 |
| takedani@ims.u-tokyo.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東京大学医科学研究所附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 9 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000011077 |